FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2024
Back to search
Official data from USPTO
AQUMELDI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AQUMELDI
ST13
US500000079357589Class
1, 5, 42, 44
Filing
79357589
Registration
7389987
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/30/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
10/28/2022
Registration date
05/21/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
05/21/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
GAYNOR, BARBARA ANNE
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Proveca Limited
Representatives
Alexandra MacKay Stites & Harbison PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in manufacturing pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of drugs for treating hypertension in children from birth through age 17; reagents for medical research; diagnostic reagents for scientific use
Class 5
Medicines for human purposes for the treatment of hypertension in children from birth through age 17; drugs for the treatment of hypertension in children from birth through age 17; chemical preparations for pharmaceutical purposesfor the treatment of hypertension in children from birth through age 17; chemical preparations for medical purposesfor the treatment of hypertension in children from birth through age 17; chemical reagents for medical purposes; diagnostic agentspreparations and substances for medical purposes; reactants for medical diagnosisdiagnostic preparations for medical purposes
Class 42
Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; research and development of vaccines and medicines; research relating to medicines; pharmaceutical product evaluationassessing the efficiency of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of chemicals
Class 44
Medical treatment of hypertension in children from birth through age 17; provision of medical assistance
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2024
FIMP
FINAL DISPOSITION PROCESSED
11/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/21/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/15/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/15/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2024
PUBO
PUBLISHED FOR OPPOSITION
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2024
RFNT
REFUSAL PROCESSED BY IB
09/25/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/15/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2023
RFRR
REFUSAL PROCESSED BY MPU
09/01/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2023
CNRT
NON-FINAL ACTION WRITTEN
08/14/2023
DOCK
ASSIGNED TO EXAMINER
08/14/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/16/2022
Continuous trademark protection
Get notified about every new filing that threatens AQUMELDI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.